Related Experiment Videos
Gene amplification and expression of the neu (c-erbB-2) sequence in human mammary carcinoma
J Fontaine1, M Tesseraux, V Klein
1Institute of Human Genetics, Medical School, University of Saar, Homburg, FRG.
Abstract:
Alterations in the structure and expression of the neu oncogene were investigated in 15 human mammary tumors. In 7 of the samples (46%), amplification by the factor up to 14 was detected, some samples displaying an additional EcoRI restriction fragment at 3.4 kb. In tumor tissue with amplified neu sequences from which intact RNA was available, enhanced expression was noted. Correlation of the molecular data to clinical parameters indicated a correlation of the neu oncogene amplification to tumor grading and thus poor prognosis.
Insights
Amplification of the neu oncogene was detected in nearly half of human breast tumors, correlating with higher tumor grade and poorer prognosis. This suggests neu oncogene alterations are significant in breast cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The neu oncogene plays a role in cell growth and differentiation.
- Alterations in oncogenes are implicated in cancer development.
- Understanding oncogene behavior in human tumors is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate structural and expression alterations of the neu oncogene in human breast tumors.
- To correlate these molecular findings with clinical parameters.
- To assess the prognostic significance of neu oncogene amplification.
Main Methods:
- Analysis of 15 human mammary tumor samples.
- Detection of gene amplification using molecular techniques.
- Assessment of gene expression using RNA analysis.
- Correlation of molecular data with clinical tumor grading.
Main Results:
- Neu oncogene amplification detected in 7 out of 15 samples (46%), up to 14-fold.
- An additional EcoRI restriction fragment at 3.4 kb was observed in some samples.
- Enhanced neu gene expression was noted in tumors with amplified sequences.
- Neu oncogene amplification correlated with higher tumor grading.
Conclusions:
- Amplification and enhanced expression of the neu oncogene occur in a significant subset of human breast tumors.
- Neu oncogene amplification is associated with poor prognostic indicators, specifically higher tumor grade.
- These findings highlight the potential role of the neu oncogene as a biomarker in breast cancer.